Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration
โ Scribed by M. S. Dai; P. F. Wu; R. Y. Shyu; J. J. Lu; T. Y. Chao
- Book ID
- 111237277
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 139 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatitis B virus (HBV) reactivation has been described in cancer patients who received cytotoxic/immunosuppressive therapy and may result in liver damage of varying degrees of severity. There is no known effective treatment. Lamivudine, a nucleoside analogue, has been found to suppress HBV replicat
## Abstract Breast cancer is a rapidly increasing problem in many developing countries, and cytotoxic chemotherapy is now an integral part of its management. In several developing countries, the carriage of hepatitis B virus (HBV) in cancer patients may be as high as 12%, and such patients are at r